Association Between RBC Antigen Allo-Antibodies and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Treatment for Advanced Cancers

Association Between RBC Antigen Allo-Antibodies and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Treatment for Advanced Cancers

Natasha A Jain,1,2 Songzhu Zhao,3 Lai Wei,3 Kerry A Rogers,1,2 Gregory A Otterson,1 Tzu-Fei Wang,2 Dwight H Owen1 1Division of Medical Oncology, The Ohio State University, Columbus, OH, USA; 2Division of Hematology, The Ohio State University, Columbus, OH, USA; 3Center for Biostatistics, The Ohio St...

Full description

Bibliographic Details
Main Authors: Jain NA, Zhao S, Wei L, Rogers KA, Otterson GA, Wang TF, Owen DH
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Cancer Management and Research
Subjects:
autoimmune hemolytic anemia
immune related adverse events
direct antiglobulin test
immunotherapy
immune checkpoint inhibitors
red blood cell allo-antibodies.
Online Access:https://www.dovepress.com/association-between-rbc-antigen-allo-antibodies-and-immune-related-adv-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/association-between-rbc-antigen-allo-antibodies-and-immune-related-adv-peer-reviewed-article-CMAR

Similar Items